Toronto Research Chemicals, TRC, was founded in 1982 by Dr. David Dime to manufacture and supply researchers in the biomedical fields with specialized complex organic small molecules that were not commercially available. In 1983, the company was incorporated in Ontario as Toronto Research Chemicals Inc. It was initially located at the University of Toronto. As the business expanded, larger facilities were required to accommodate the growth.

Today, Toronto Research Chemicals Inc. employs about 140 full time staff, of which approximately 80 are PHD’s, operating in a 65,000 square foot facility. TRC, currently manufactures and distributes in excess of 27,000 products to more than 65 countries.

Product Line:

Today, TRC’s product lines include unique highly specialized chemicals for drug development, medical, biopharmaceutical and biochemical research. Many of these compounds are proprietary and developed in our laboratories through an innovative research and development process. They include the following areas.

  • APIs, impurities and Metabolites
  • Stable isotope labeled analogues

  • Building blocks
  • Carbohydrates and Oligosaccharides

  • Nucleic acid derivatives
  • Glycosidase Inhibitors

  • Enzyme Activators and Inhibitors
  • Sulfhydryl active reagents

  • Fluorescent reagents and spin labels
  • Nicotine Derivatives

  • Neurochemicals
  • Environmental compounds Mutagens, and Metabolites

  • Phthalates
  • Retinoids

  • Vitamin D derivatives
  • Drugs of Abuse/ Forensics

  • Phosphates
  • Forensics; fentanyls, steroids, opiates, benzodiazepines, barbituates, canabinols, phenethylamines, phenecyclidines, methadones/analogues, ecgonines, tryptamines, JWH compounds.

Most products are available in their stable isotope labeled analogues.